[go: up one dir, main page]

GB0026239D0 - Surface active lipids in treatment of wet lung - Google Patents

Surface active lipids in treatment of wet lung

Info

Publication number
GB0026239D0
GB0026239D0 GBGB0026239.4A GB0026239A GB0026239D0 GB 0026239 D0 GB0026239 D0 GB 0026239D0 GB 0026239 A GB0026239 A GB 0026239A GB 0026239 D0 GB0026239 D0 GB 0026239D0
Authority
GB
United Kingdom
Prior art keywords
treatment
surface active
wet lung
active lipids
lipids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0026239.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Britannia Pharmaceuticals Ltd
Original Assignee
Britannia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Britannia Pharmaceuticals Ltd filed Critical Britannia Pharmaceuticals Ltd
Priority to GBGB0026239.4A priority Critical patent/GB0026239D0/en
Publication of GB0026239D0 publication Critical patent/GB0026239D0/en
Priority to GB0125752A priority patent/GB2370505A/en
Priority to AU2002210720A priority patent/AU2002210720A1/en
Priority to PCT/GB2001/004761 priority patent/WO2002034270A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0026239.4A 2000-10-26 2000-10-26 Surface active lipids in treatment of wet lung Ceased GB0026239D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0026239.4A GB0026239D0 (en) 2000-10-26 2000-10-26 Surface active lipids in treatment of wet lung
GB0125752A GB2370505A (en) 2000-10-26 2001-10-26 Use of a surface active phospholipid in the manufacture of a powder medicament for the treatment of wet lung
AU2002210720A AU2002210720A1 (en) 2000-10-26 2001-10-26 Treatment of respiratory distress syndrome with powder surfactant composition
PCT/GB2001/004761 WO2002034270A1 (en) 2000-10-26 2001-10-26 Treatment of respiratory distress syndrome with powder surfactant composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0026239.4A GB0026239D0 (en) 2000-10-26 2000-10-26 Surface active lipids in treatment of wet lung

Publications (1)

Publication Number Publication Date
GB0026239D0 true GB0026239D0 (en) 2000-12-13

Family

ID=9902029

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0026239.4A Ceased GB0026239D0 (en) 2000-10-26 2000-10-26 Surface active lipids in treatment of wet lung
GB0125752A Withdrawn GB2370505A (en) 2000-10-26 2001-10-26 Use of a surface active phospholipid in the manufacture of a powder medicament for the treatment of wet lung

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0125752A Withdrawn GB2370505A (en) 2000-10-26 2001-10-26 Use of a surface active phospholipid in the manufacture of a powder medicament for the treatment of wet lung

Country Status (3)

Country Link
AU (1) AU2002210720A1 (en)
GB (2) GB0026239D0 (en)
WO (1) WO2002034270A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004024123A1 (en) * 2002-09-16 2004-03-25 Vasogen Ireland Limited Accelerating recovery from trauma
WO2004082688A1 (en) * 2003-03-20 2004-09-30 Vasogen Ireland Limited Phosphatidylglycerol (pg) receptor agonists and antagonists
EP2308489B1 (en) * 2009-10-05 2014-01-01 Nutri-Fit GmbH & Co. KG Compositions for use in treating or preventing metabolic stress-induced lung injury and methods for increasing physical capacity of mammalian livestock

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4312860A (en) * 1980-10-24 1982-01-26 Regents Of The University Of California Lung surfactant compositions
JPS58222022A (en) * 1982-06-21 1983-12-23 Teijin Ltd Synthetic pulmonary surface active substance and remedy for respiratory distress syndrome (rds) containing the same as active constituent
EP0110498B2 (en) * 1982-11-22 1991-09-18 Teijin Limited Artificial lung surfactant and remedy for respiratory distress syndrome containing it as active principle
JPS59164724A (en) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd Surfactant and remedy for respiratory distress syndrome containing the same
US5614216A (en) * 1990-10-17 1997-03-25 The Liposome Company, Inc. Synthetic lung surfactant
BR9506114A (en) * 1994-12-29 1997-12-23 Ctro Nac Sanidad Agropecuaria Pulmonary surfactant of porcine origin and process for obtaining it
ATE229799T1 (en) * 1997-12-03 2003-01-15 Britannia Pharmaceuticals Ltd USE OF PHOSPHOLIPIDES IN THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF ASTHMA
DE19827907C2 (en) * 1998-06-23 2003-05-15 Altana Pharma Ag New pharmaceutical compositions for the treatment of IRDS and ARDS

Also Published As

Publication number Publication date
GB0125752D0 (en) 2001-12-19
AU2002210720A1 (en) 2002-05-06
GB2370505A (en) 2002-07-03
WO2002034270A1 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
GB2379866B (en) Wet/dry floor cleaning unit and method of cleaning
IL150628A0 (en) Use of lipid conjugates in the treatment of disease
HK1055752A1 (en) Surface treatment of medical device
AU6216801A (en) Substantially dry cleansing product of improved latherability and wet flexibility
IL155092A0 (en) Compounds useful in the treatment of inflammatory diseases
AU2001262168A1 (en) Substantially dry cleansing product of improved latherability and wet flexibility
GB0016787D0 (en) Compounds useful in therapy
AU2002243363A8 (en) Use of aziridino-compounds in the treatment of immune dysfunctions
SI1197485T1 (en) Cyclobuten-dione derivatives for use in the treatment of artherosclerosis
GB0026239D0 (en) Surface active lipids in treatment of wet lung
AU2001236929A1 (en) Surface treatment
AU4746601A (en) Ion conducting ceramic membrane and surface treatment
EP1337265A4 (en) Methods of treatment comprising administration of substance p
AU2002217064A1 (en) Novel use of phospholipids in hair treatment products
IL154168A0 (en) Improved specificity in treatment of diseases
TW435219U (en) Improved structure of beating massage device
TW423322U (en) Improved structure of massage pad
GB0014046D0 (en) Compounds useful in therapy
GB9725640D0 (en) Use of surface-active phospholipids in asthma treatment
GB2358376B (en) Surface treatment of flooring material
GB0012945D0 (en) Use of compounds in therapy
GB0030058D0 (en) Use of compounds in therapy
TW510219U (en) Massage mat
GB0230009D0 (en) Treatment using surface active phospholipids
GB0201885D0 (en) Treatment using surface active phospholipids

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)